OGN:NYSE
Organon & Co
$13.89
arrow_downward
-0.18%(-0.025) 1D
$13.89
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
$13.89
High
$13.91
Low
$13.89
Mkt. cap
3.65B
Avg. vol.
2.72M
Volume
3.57M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
18.07
52-wk high
$13.94
52-wk low
$5.69
EPS
$0.77
Beta
1.53
Shares outstanding
262.62M
No. of employees
10K
Open
$13.89
High
$13.91
Low
$13.89
Mkt. cap
3.65B
Avg. vol.
2.72M
Volume
3.57M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
18.07
52-wk high
$13.94
52-wk low
$5.69
EPS
$0.77
Beta
1.53
Shares outstanding
262.62M
No. of employees
10K
News stories
From web sources and news partners
The Motley Fool
·
13 minutes ago
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
FOREX.com
·
3 hours ago
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingKey
·
10 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
4 hours ago
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com